Analystreport

Can-Fite Biopharma Ltd (NASDAQ: CANF) had its "buy" rating re-affirmed by analysts at HC Wainwright.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares  (CANF) 
NASDAQ:AMEX Investor Relations: ir.canfite.com